Buffalo Bulletin
Semaglutide's Cardiovascular Outcomes Trial Data The SUSTAIN-6 trial followed over 3,297 people with type 2 diabetes for more than three years and found that semaglutide reduced the combined risk of heart attack, stroke, and cardiovascular death by 26% compared to placebo
Growth Hormone Receptor Pathway Modulation BPC-157 demonstrates significant effects on the growth hormone receptor (GHR) signaling system, particularly relevant to musculoskeletal tissue repair
Bile acids play a key role in governing cholesterol homeostasis and solubilization and account for roughly two-thirds of the solute mass of human bile by weight
Furthermore, one study reported that co-administration of NAC and metformin for 12 months in patients with nonalcoholic steatohepatitis (NASH) decreased serum FBS, fasting insulin and insulin resistance, HDL-C, and TG levels but did not change serum concentrations of TC (35)
High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease